Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Revenue (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Revenue for 6 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Dec 2025, changed 0.07% year-over-year, with the annual reading at $7.7 million for FY2025, 0.07% changed from the prior year.
  • Revenue hit $2.5 million in Q4 2025 for Bolt Biotherapeutics, up from $2.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $5.3 million in Q1 2024 to a low of $508000.0 in Q4 2021.
  • Historically, Revenue has averaged $1.8 million across 5 years, with a median of $1.4 million in 2023.
  • Biggest five-year swings in Revenue: surged 188.83% in 2024 and later plummeted 76.83% in 2025.
  • Year by year, Revenue stood at $508000.0 in 2021, then surged by 177.76% to $1.4 million in 2022, then soared by 48.05% to $2.1 million in 2023, then crashed by 45.38% to $1.1 million in 2024, then surged by 119.11% to $2.5 million in 2025.
  • Business Quant data shows Revenue for BOLT at $2.5 million in Q4 2025, $2.2 million in Q3 2025, and $1.8 million in Q2 2025.